Taylor Frigon Capital Management LLC Edwards Lifesciences Corp Transaction History

Taylor Frigon Capital Management LLC

$199 Million
Q3 2024

A detailed history of Taylor Frigon Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Taylor Frigon Capital Management LLC holds 30,348 shares of EW stock, worth $2.27 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

30,348

Previous 33,283 8.82%

Holding current value

$2.27 Million

Previous $3.07 Million 34.87%

% of portfolio

1.01%

Previous 1.48%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$59.7 - $93.78 $175,219 - $275,244	-2,935 Reduced 8.82%	30,348 $2 Million
Q2 2024 Jul 29, 2024	BUY	$84.3 - $94.31 $359,539 - $402,232	4,265 Added 14.7%	33,283 $3.07 Million
Q1 2024 Apr 19, 2024	SELL	$72.54 - $95.56 $20,093 - $26,470	-277 Reduced 0.95%	29,018 $2.77 Million
Q4 2023 Jan 29, 2024	SELL	$61.71 - $77.76 $12,403 - $15,629	-201 Reduced 0.68%	29,295 $2.23 Million
Q3 2023 Oct 25, 2023	BUY	$69.28 - $93.38 $2,424 - $3,268	35 Added 0.12%	29,496 $2.04 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $65,860 - $76,312	-809 Reduced 2.67%	29,461 $2.78 Million
Q1 2023 Apr 25, 2023	SELL	$74.26 - $84.51 $24,431 - $27,803	-329 Reduced 1.08%	30,270 $2.5 Million
Q4 2022 Feb 03, 2023	SELL	$68.3 - $87.44 $120,959 - $154,856	-1,771 Reduced 5.47%	30,599 $2.28 Million
Q3 2022 Nov 04, 2022	BUY	$82.37 - $107.29 $7,330 - $9,548	89 Added 0.28%	32,370 $2.68 Million
Q2 2022 Aug 04, 2022	SELL	$86.5 - $128.27 $197,306 - $292,583	-2,281 Reduced 6.6%	32,281 $3.07 Million
Q1 2022 Apr 25, 2022	SELL	$101.96 - $128.34 $11,317 - $14,245	-111 Reduced 0.32%	34,562 $4.07 Million
Q4 2021 Jan 21, 2022	SELL	$106.37 - $130.68 $12,126 - $14,897	-114 Reduced 0.33%	34,673 $4.49 Million
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $34,063 - $40,630	331 Added 0.96%	34,787 $3.94 Million
Q2 2021 Jul 26, 2021	SELL	$83.84 - $104.76 $78,474 - $98,055	-936 Reduced 2.64%	34,456 $3.57 Million
Q1 2021 Apr 23, 2021	SELL	$78.68 - $90.67 $2,360 - $2,720	-30 Reduced 0.08%	35,392 $2.96 Million
Q4 2020 Jan 22, 2021	BUY	$71.69 - $91.23 $116,639 - $148,431	1,627 Added 4.81%	35,422 $3.23 Million
Q3 2020 Oct 20, 2020	BUY	$67.19 - $87.44 $29,765 - $38,735	443 Added 1.33%	33,795 $2.7 Million
Q2 2020 Jul 22, 2020	BUY	$57.54 - $76.95 $1.29 Million - $1.73 Million	22,439 Added 205.62%	33,352 $2.31 Million
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $92,765 - $143,370	1,770 Added 19.36%	10,913 $2.06 Million
Q1 2020 Apr 24, 2020	SELL	$52.41 - $81.0 $7,337 - $11,340	-140 Reduced 1.51%	9,143 $1.73 Million
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $141,249 - $161,717	-1,970 Reduced 17.51%	9,283 $2.17 Million
Q3 2019 Nov 01, 2019	SELL	$61.55 - $75.43 $19,757 - $24,213	-321 Reduced 2.77%	11,253 $2.48 Million
Q2 2019 Jul 17, 2019	BUY	$55.74 - $64.41 $42,975 - $49,660	771 Added 7.14%	11,574 $2.14 Million
Q1 2019 Apr 25, 2019	SELL	$47.89 - $64.05 $18,102 - $24,210	-378 Reduced 3.38%	10,803 $2.07 Million
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $649 - $797	-14 Reduced 0.13%	11,181 $1.71 Million
Q3 2018 Oct 15, 2018	SELL	$45.7 - $58.03 $85,596 - $108,690	-1,873 Reduced 14.33%	11,195 $1.95 Million
Q2 2018 Aug 01, 2018	SELL	$42.45 - $51.3 $23,092 - $27,907	-544 Reduced 4.0%	13,068 $1.9 Million
Q1 2018 Apr 23, 2018	SELL	$37.19 - $47.45 $243,111 - $310,180	-6,537 Reduced 32.44%	13,612 $1.9 Million
Q4 2017 Jan 25, 2018	BUY	$33.79 - $39.39 $680,834 - $793,669	20,149	20,149 $2.27 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.

Account

Taylor Frigon Capital Management LLC Edwards Lifesciences Corp Transaction History